股本结构
单位：万股
| 公告日期 | 2024-04-29 | 2024-04-11 | 2024-04-05 | 2024-03-08 | 2024-03-08 | 2023-12-15 |
|---|---|---|---|---|---|---|
| 证券总股本 | 238.63 | 82.86 | 30.89 | 617.89 | 588.69 | 588.69 |
| 普通股本 | 238.63 | 82.86 | 30.89 | 617.89 | 588.69 | 588.69 |
| 优先股 | 0.0066 | 0.13 | 未披露 | 0.13 | 0.14 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-04-26 | 2024-04-11 | 2024-04-09 | 2024-02-21 | 2023-12-31 | 2023-12-13 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-04-29 | 238.63 | 0.0066 | 定期报告 | 2024-04-26 |
| 2024-04-11 | 82.86 | 0.13 | 定期报告 | 2024-04-11 |
| 2024-04-05 | 30.89 | 未披露 |
更多>>
1-for-20 Reverse Stock Split
|
2024-04-09 |
| 2024-03-08 | 617.89 | 0.13 | 定期报告 | 2024-02-21 |
| 2024-03-08 | 588.69 | 0.14 |
更多>>
From December 31,2022 to December 31,2023
Cashless exercise of Exchange Warrants
September 2023 warrants exercised on inducement, net
Issuance of common stock, net July 2023 financing
Issuance of common stock, net, April 2023 Financing
Conversion of Series A Preferred Stock into common stock, net
Round up of common shares issued as a result of 1-for-35 and 1-for-40 reverse stock splits
|
2023-12-31 |
| 2023-12-15 | 588.69 | 未披露 | 定期报告 | 2023-12-13 |
| 2023-12-06 | 482.46 | 未披露 | 定期报告 | 2023-12-01 |
| 2023-11-14 | 455.86 | 未披露 | 定期报告 | 2023-11-08 |
| 2023-11-14 | 418.56 | 0.14 |
更多>>
From June 30, 2023 to September 30, 2023
Redemption of Series A shares
Issuance of common stock, net July 2023 financing
September 2023 warrants exercised on inducement, net
|
2023-09-30 |
| 2023-08-14 | 272.88 | 未披露 | 定期报告 | 2023-08-10 |
| 2023-07-07 | 86.08 | 未披露 |
更多>>
Common Stock offered by the company 357,223 shares
|
2023-07-10 |
| 2023-08-14 | 50.36 | 0.60 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock, net, April 2023 Financing
Round up of common shares issued as a result of 1-for-40 reverse stock splitConversion of Series A Preferred Stock into common stock
|
2023-06-30 |
| 2023-06-30 | 50.36 | 0.60 |
更多>>
Allarity Therapeutics, Inc. announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 40 pre-split shares.
|
2023-06-29 |
| 2023-06-07 | 2014.26 | 0.60 | 定期报告 | 2023-06-05 |
| 2023-06-06 | 1914.33 | 0.67 | 定期报告 | 2023-05-30 |
| 2023-05-11 | 1914.33 | 未披露 | 定期报告 | 2023-05-11 |
| 2023-04-20 | 911.68 | 未披露 |
更多>>
Common Stock offered 2,869,330 shares by the company
|
2023-04-21 |
| 2023-04-20 | 624.74 | 未披露 | 定期报告 | 2023-04-18 |
| 2023-05-11 | 118.84 | 5.97 |
更多>>
From December 31, 2022 to March 31, 2023
Round up of common shares issued as a result of 1-for-35 reverse stock split
Conversion of Preferred Stock into common stock, net
|
2023-03-31 |
| 2023-03-24 | 97.98 | 未披露 |
更多>>
Allarity Therapeutics, Inc. announced that it intends to effect a reverse stock split of its common stock, at a ratio of 1 post split share for every 35 pre-split shares. The reverse stock split will become effective at 4:05 p.m. New York Time on Friday, March 24, 2023 (the “Effective Time”).
|
2023-03-27 |
| 2023-03-24 | 3429.46 | 未披露 | 定期报告 | 2023-03-24 |
| 2023-03-06 | 3000.00 | 5.00 | 定期报告 | 2023-03-03 |
| 2023-01-23 | 2454.12 | 1.17 | 定期报告 | 2023-01-23 |
| 2023-03-13 | 1589.78 | 1.36 |
更多>>
From December 31, 2021 to December 31, 2022
Conversion of preferred stock into common stock
Series B preferred stock dividend
|
2022-12-31 |
| 2022-12-23 | 1442.84 | 1.39 | 定期报告 | 2022-12-22 |
| 2022-12-21 | 1379.36 | 1.40 | 定期报告 | 2022-12-20 |
| 2022-12-12 | 1038.12 | 未披露 | 定期报告 | 2022-12-09 |
| 2022-12-06 | 1026.02 | 20.60 | 定期报告 | 2022-12-05 |
| 2022-10-07 | 1026.02 | 1.52 | 定期报告 | 2022-10-07 |
| 2022-09-19 | 1026.02 | 未披露 | 定期报告 | 2022-09-15 |
| 2022-08-12 | 994.40 | 1.58 | 定期报告 | 2022-08-12 |
| 2022-08-02 | 972.38 | 1.62 | 定期报告 | 2022-08-01 |
| 2022-06-07 | 928.33 | 1.70 | 定期报告 | 2022-05-31 |
| 2022-05-27 | 928.33 | 未披露 | 定期报告 | 2022-05-27 |
| 2022-04-01 | 884.23 | 1.78 | 定期报告 | 2022-03-30 |
| 2022-05-17 | 809.60 | 1.98 |
更多>>
From December 31, 2020 to December 31, 2021
Units issued for cash
Shares issued for cash – exercise of warrants
Convertible debt conversion and debt settlement
Shares issued for services
Share issuance costs
Conversion of preferred stock into common stock
|
2021-12-31 |
| 2021-12-21 | 807.58 | 未披露 | 定期报告 | 2021-12-21 |
1-for-20 Reverse Stock Split
From December 31,2022 to December 31,2023
Cashless exercise of Exchange Warrants
September 2023 warrants exercised on inducement, net
Issuance of common stock, net July 2023 financing
Issuance of common stock, net, April 2023 Financing
Conversion of Series A Preferred Stock into common stock, net
Round up of common shares issued as a result of 1-for-35 and 1-for-40 reverse stock splits
From June 30, 2023 to September 30, 2023
Redemption of Series A shares
Issuance of common stock, net July 2023 financing
September 2023 warrants exercised on inducement, net
Common Stock offered by the company 357,223 shares
From March 31, 2023 to June 30, 2023
Issuance of common stock, net, April 2023 Financing
Round up of common shares issued as a result of 1-for-40 reverse stock splitConversion of Series A Preferred Stock into common stock
Allarity Therapeutics, Inc. announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 40 pre-split shares.
Common Stock offered 2,869,330 shares by the company
From December 31, 2022 to March 31, 2023
Round up of common shares issued as a result of 1-for-35 reverse stock split
Conversion of Preferred Stock into common stock, net
Allarity Therapeutics, Inc. announced that it intends to effect a reverse stock split of its common stock, at a ratio of 1 post split share for every 35 pre-split shares. The reverse stock split will become effective at 4:05 p.m. New York Time on Friday, March 24, 2023 (the “Effective Time”).
From December 31, 2021 to December 31, 2022
Conversion of preferred stock into common stock
Series B preferred stock dividend
From December 31, 2020 to December 31, 2021
Units issued for cash
Shares issued for cash – exercise of warrants
Convertible debt conversion and debt settlement
Shares issued for services
Share issuance costs
Conversion of preferred stock into common stock